Introduction: Lennox-Gastaut Syndrome (LGS) is a rare and severe form of childhood-onset epilepsy characterized by multiple seizure types, intellectual disability, and abnormal EEG patterns. It presents a significant clinical challenge due to its refractoriness to conventional antiepileptic drugs (AEDs) and its profound impact on patients’ quality of life. The Lennox-Gastaut Syndrome market encompasses a spectrum […]
Tag: Lennox Gastaut Syndrome Market
Back To Top